PeerJ · 2026
Assessing COVID-19 vaccine hesitancy in Malaysian pregnant women: prevalence and influencing factors.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ginon Norhidayu, Mat Yudin Zainab, W Ahmad Wan Muhamad Amir, Abdul Kadir Azidah, Norhayati Mohd Noor, Mohamad Zon Erinna, Ali Norsiah, Abdul Rahman Ahmad Fithri Azam, Abdullah Nur Harnani, Kamaludin Nadia Hamimah, Zainuddin Norazlin, Amaran Asma, Kasim Rosnani, Mohd Nazri Norzarina Ireny, Arinima Punitha, Ahmad Zawawi Mohamad Ariff Fahmi
Аннотация
BACKGROUND: The World Health Organization has highlighted vaccine hesitancy as one of the top ten threats to global health, and the recent COVID-19 pandemic has demonstrated the importance of vaccination as one of the successful preventive measures, especially for high-risk groups, including pregnant women. This study aims to determine the prevalence of COVID-19 vaccine hesitancy and its influencing factors among pregnant women in Malaysia.
METHODS: This cross-sectional study was conducted from June 2024 to December 2024. among pregnant women at an antenatal clinic in Malaysia. Participants were selected using a non-proportionate stratified multistage cluster random sampling. The vaccine hesitancy status is measured by the Pregnancy Vaccine Hesitancy Scale (pVHS). Data were collected using a self-administered questionnaire, available through Google Forms or in printed form.
RESULTS: A total of 595 pregnant women participated (response rate: 99.2%). The prevalence of COVID-19 vaccine hesitancy was 42.5%. Vaccine hesitancy was significantly associated with incomplete or non-receipt of COVID-19 vaccination (p = 0.022), having family or friends who experienced severe vaccine side effects (p = 0.020), and lower knowledge scores regarding COVID-19 infection and vaccination (p < 0.001).
CONCLUSION: These findings underscore the importance of targeted communication strategies in addressing vaccine hesitancy among pregnant women. Moreover, involving healthcare providers in disseminating accurate information and addressing patients' concerns can be crucial in increasing vaccine acceptance among pregnant women.
METHODS: This cross-sectional study was conducted from June 2024 to December 2024. among pregnant women at an antenatal clinic in Malaysia. Participants were selected using a non-proportionate stratified multistage cluster random sampling. The vaccine hesitancy status is measured by the Pregnancy Vaccine Hesitancy Scale (pVHS). Data were collected using a self-administered questionnaire, available through Google Forms or in printed form.
RESULTS: A total of 595 pregnant women participated (response rate: 99.2%). The prevalence of COVID-19 vaccine hesitancy was 42.5%. Vaccine hesitancy was significantly associated with incomplete or non-receipt of COVID-19 vaccination (p = 0.022), having family or friends who experienced severe vaccine side effects (p = 0.020), and lower knowledge scores regarding COVID-19 infection and vaccination (p < 0.001).
CONCLUSION: These findings underscore the importance of targeted communication strategies in addressing vaccine hesitancy among pregnant women. Moreover, involving healthcare providers in disseminating accurate information and addressing patients' concerns can be crucial in increasing vaccine acceptance among pregnant women.